These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17256762)

  • 1. Treatment of hepatocellular carcinoma after transplantation and human rights.
    Crippin JS
    Hepatology; 2007 Feb; 45(2):263-5. PubMed ID: 17256762
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation.
    Mancuso A; Airoldi A; Vigano R; Pinzello G
    Dig Liver Dis; 2011 Sep; 43(9):754. PubMed ID: 21641889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver transplantation for hepatocellular carcinoma].
    Decaens T; Hurtova M; Duvoux C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):61-9. PubMed ID: 19108968
    [No Abstract]   [Full Text] [Related]  

  • 4. Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?
    Kanmematsu T
    Hepatogastroenterology; 1996; 43(12):1404. PubMed ID: 8975938
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
    Majno P; Giostra E; Mentha G
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S27-35. PubMed ID: 17969086
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hepatocellular carcinoma in cirrhosis: locoregional therapies for bridging to liver transplant.
    Lee FT
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S24-6. PubMed ID: 17969066
    [No Abstract]   [Full Text] [Related]  

  • 7. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation.
    Zhuang L; Mou HB; Yu LF; Zhu HK; Yang Z; Liao Q; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):91-93. PubMed ID: 31706859
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma: the Hangzhou experience.
    Busuttil RW
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):235-6. PubMed ID: 18522877
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver transplantation for hepatocellular carcinoma.
    Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
    J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing access to liver transplantation: implications for gastroenterology practice.
    Brown R; Emond JC
    Gastroenterology; 2007 Mar; 132(3):1152-63. PubMed ID: 17383434
    [No Abstract]   [Full Text] [Related]  

  • 13. Selecting patients with hepatocellular carcinoma for transplantation.
    Piscaglia F; Gianstefani A; Righini R; Bolondi L
    Liver Transpl; 2007 Aug; 13(8):1203; author reply 1204. PubMed ID: 17663399
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver allocation for patients with hepatocellular carcinoma.
    Neuberger J
    Liver Transpl; 2010 Mar; 16(3):249-51. PubMed ID: 20209584
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).
    Printz C
    Cancer; 2009 Oct; 115(20):4646. PubMed ID: 19806596
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrence of hepatocellular carcinoma after liver transplantation presenting with massive intrahepatic bleeding.
    Donadon M; Giacomoni A; Lauterio A; Slim A; Pirotta V; Mangoni I; De Carlis L
    Liver Transpl; 2008 Feb; 14(2):259-61. PubMed ID: 18236411
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 19. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 20. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.